Ignite Creation Date:
2025-12-24 @ 1:38 PM
Ignite Modification Date:
2026-05-22 @ 1:49 AM
Study NCT ID:
NCT03987295
Status:
COMPLETED
Last Update Posted:
2025-12-05
First Post:
2019-05-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2)
Sponsor:
Alector Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AL001-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |